| SH | Salter-Harris [fracture]; Schonlein-Henoch [purpura]; self-help; serum hepatitis; sexual harassment;... |
|---|---|
| BMS | Bachelor of Medical Science; betamethasone; biomedical monitoring system; biomedical science; bleomy... |
| BSN | baccalaureate of science in nursing; Bachelor of Science in Nursing; bowel sounds normal |
| DOS | day of surgery; deoxystreptamine; disk operating system; Doctor of Ocular Science; Doctor of Optical... |
| CAS | calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car... |
acute angle
| history of medicine, early modern | The period of the history of medicine from 1451 through 1600 a.d. History of medicine, 15th cent. And history of medicine, 16th cent. Are also available. (12 Dec 1998) |
|---|---|
| history of medicine, medieval | The period of the history of medicine from 500 through 1450 a.d. (12 Dec 1998) |
| history of medicine, modern | The period of the history of medicine from 1601 a.d. To the present. (12 Dec 1998) |
| natural history | A former branch of knowledge embracing the study, description, and classification of natural objects (as animals, plants, and minerals) and thus including the modern sciences of zoology, botany, and mineralogy insofar as they existed at that time. In the 17th, 18th, and 19th centuries it was much used for the generalised pursuit of certain areas of science. (webster, 3d ed; from dr. James h. Cassedy, nlm history of medicine division) (12 Dec 1998) |
| family history | The medical history of your immediate blood relatives (mother, father, grandparents and siblings) (27 Sep 1997) |
| retrospective studies | Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. (12 Dec 1998) |
| pharmalogical studies | <pharmacology> Studies to assess the potential harmful or other effects of drugs (16 Dec 1997) |
| clinical studies | <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product. (14 Nov 1997) |
| cohort studies | Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. (12 Dec 1998) |
| combination studies | <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs. (09 Jan 1998) |
| multicenter studies | Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. (12 Dec 1998) |
| multivariate studies | The use of statistical techniques for the simultaneous investigations of the influence of several variables. (05 Mar 2000) |
| preclinical studies | <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application. (14 Nov 1997) |
| sampling studies | Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled. (12 Dec 1998) |
| prospective studies | Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. (12 Dec 1998) |